FDA Advisory Panel Votes to Loosen Rules on BPC-157, TB-500, and MOTS-C Despite Agency Scientists' Opposition An FDA advisory committee voted narrowly on July 23, 2026, to recommend that compounding pharmacies gain access to several popular peptide compounds, including BPC-157, KPV, TB-500, and MOTS-C, overriding explicit objections from the FDA's own career scientists and sparking an audible gasp in the meeting room when the tally was announced
We are definitely not trying to get rid of their practice
A great way to support keratin production is to also consider incorporating OMI Hair Growth Peptides which contain patented IFP Hair Growth Factor, a patented form of keratin peptides clinically shown to reduce hair loss and promote hair follicle anchoring
Systemic, I don't know if people get systemic effect to me
This directly conflicts with the metabolic goals of retatrutide therapy and could undermine any intended benefit
Meets USP standards for injection-use water